Top Markets
#1 PulseChain PulseChain +45.01%
#2 Glidr Glidr +14.18%
#3 Fake World Assets Fake World Assets +9.73%
#4 eCash eCash +7.63%
#5 DeFi Kingdoms DeFi Kingdoms +7.52%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.80%
#7 OPENLOOT OPENLOOT +6.78%
#8 Qkacoin Qkacoin +6.48%
#9 Meteora Meteora +5.79%
#10 Bitcoin SV Bitcoin SV +5.63%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd

017180
Rank in Stocks #28186
MYUNGMOON Pharm Co., Ltd. operates as a pharmaceutical enterprise,... MYUNGMOON Pharm Co., Ltd. operates as a pharmaceutical enterprise, comprehensively handling the research, development, production, distribution, and commercialization of medicinal products. Its business activities extend across South Korea and into global markets. The company offers an extensive array of prescription drugs, addressing a broad spectrum of medical conditions. This range includes treatments for musculoskeletal issues like osteoarthritis, inflammation, rheumatoid arthritis, and muscle relaxation, alongside anti-infectives (antibiotics and antifungals), respiratory aids, and gastrointestinal therapeutics. Cardiovascular health is targeted with circulation agents, anti-hypertensive drugs, and antidiabetic medications. Furthermore, their specialized pharmacotherapy solutions cover narcotics, anesthetics, central nervous system agents, female hormone products, osteoporosis treatments, urogenital medications, adrenocortical hormones, oncology drugs, dermal fillers, and anti-obesity agents. Beyond prescription items, MYUNGMOON Pharm also supplies a diverse selection of over-the-counter (OTC) remedies. These encompass medications for nausea, genitourinary concerns, gum disease, liver support, parasitic infections, constipation, oral ailments, diarrhea, and general digestive health. The OTC portfolio further includes cold and flu treatments, calcium supplements, nasal sprays, multi-vitamins, eye nutrition products, eye drops, blood circulation enhancers, and topical preparations such as external skin treatments and localized pain relievers. In addition to its pharmaceutical lines, the firm markets health supplements, quasi-pharmaceuticals, and blended juice beverages. Established in 1983, MYUNGMOON Pharm Co., Ltd. maintains its primary corporate office in Seoul, South Korea.
Share Price
$0.83739873
Market Cap
$27.99M
Change (1 day)
1.25%
Change (1 year)
-30.36%
Country
KR
Trade MYUNGMOON Pharm co.,Ltd (017180)

Category

Healthcare
Revenue for MYUNGMOON Pharm co.,Ltd (017180)
Revenue in Aug 2026 TTM: 0
According to MYUNGMOON Pharm co.,Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for MYUNGMOON Pharm co.,Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN